Literature DB >> 19887590

Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures.

Hiroto Mizushima1, Xiaobiao Wang, Shingo Miyamoto, Eisuke Mekada.   

Abstract

The extracellular environment and tissue architecture contribute to proper cell function and growth control. Cells growing in monolayers on standard polystyrene tissue culture plates differ in their shape, growth rate and response to external stimuli, compared with cells growing in vivo. Here, we showed that the EGFR (epidermal growth factor receptor) ligand heparin-binding EGF-like growth factor (HB-EGF) strongly stimulated cell growth in nude mice, but not in cells cultured in vitro. We explored the effects of HB-EGF on cell growth under various cell culture conditions and found that growth promotion by HB-EGF was needed in three-dimensional (3D) or two-dimensional (2D) culture systems in which cell-matrix adhesion was reduced. Under such conditions, cell growth was extremely suppressed in the absence of HB-EGF, but markedly potentiated in the presence of HB-EGF. When the integrin signal was reduced using antibodies or knockout of either integrin beta1 or focal adhesion kinase (FAK), cells showed HB-EGF-dependent growth. We also showed that EGF, transforming growth factor-alpha (TGFalpha) or ligands of other receptor tyrosine kinases (RTKs) stimulated cell growth in 3D culture, but not in tissue culture plates. These results indicate that the integrin signal was sufficient to support cell growth in 2D tissue culture plates without addition of the growth factor, whereas stimulation by growth factors was clearly demonstrated in culture systems in which integrin signals were attenuated.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887590     DOI: 10.1242/jcs.054551

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  16 in total

Review 1.  Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1.

Authors:  Yoshikazu Takada; Yoko K Takada; Masaaki Fujita
Journal:  Cytokine Growth Factor Rev       Date:  2017-02-03       Impact factor: 7.638

2.  In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents.

Authors:  Brad Shrum; Penny Costello; Warren McDonald; Christopher Howlett; Marisa Donnelly; Vivian C McAlister
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

3.  Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody.

Authors:  Dong Hoon Shin; Hye-Young Min; Adel K El-Naggar; Scott M Lippman; Bonnie Glisson; Ho-Young Lee
Journal:  Mol Cancer Ther       Date:  2011-10-06       Impact factor: 6.261

4.  Cross-talk between integrin α6β4 and insulin-like growth factor-1 receptor (IGF1R) through direct α6β4 binding to IGF1 and subsequent α6β4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions.

Authors:  Masaaki Fujita; Katsuaki Ieguchi; Parastoo Davari; Satoshi Yamaji; Yukimasa Taniguchi; Kiyotoshi Sekiguchi; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

Review 5.  Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma - a Review.

Authors:  Irmak Ayvaz; Dilara Sunay; Ece Sariyar; Esra Erdal; Zeynep Firtina Karagonlar
Journal:  J Gastrointest Cancer       Date:  2021-12-20

6.  Combating resistance to anti-IGFR antibody by targeting the integrin β3-Src pathway.

Authors:  Dong Hoon Shin; Hyo-Jong Lee; Hye-Young Min; Sun Phil Choi; Mi-Sook Lee; Jung Weon Lee; Faye M Johnson; Kapil Mehta; Scott M Lippman; Bonnie S Glisson; Ho-Young Lee
Journal:  J Natl Cancer Inst       Date:  2013-10-03       Impact factor: 13.506

7.  Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.

Authors:  Masaaki Fujita; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

8.  A 3D printed nano bone matrix for characterization of breast cancer cell and osteoblast interactions.

Authors:  Wei Zhu; Nathan J Castro; Haitao Cui; Xuan Zhou; Benchaa Boualam; Robert McGrane; Robert I Glazer; Lijie Grace Zhang
Journal:  Nanotechnology       Date:  2016-06-27       Impact factor: 3.874

9.  An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.

Authors:  Masaaki Fujita; Katsuaki Ieguchi; Dora M Cedano-Prieto; Andrew Fong; Charles Wilkerson; Jane Q Chen; Mac Wu; Su-Hao Lo; Anthony T W Cheung; Machelle D Wilson; Robert D Cardiff; Alexander D Borowsky; Yoko K Takada; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2013-05-21       Impact factor: 5.157

10.  Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer.

Authors:  Isabelle Dufau; Céline Frongia; Flavie Sicard; Laure Dedieu; Pierre Cordelier; Frédéric Ausseil; Bernard Ducommun; Annie Valette
Journal:  BMC Cancer       Date:  2012-01-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.